Printer Friendly

Ginkgo biloba extract for treatment-resistant schizophrenia.

Forty-two patients with chronic, treatment-resistant schizophrenia who were maintained on optimal doses of clozapine were randomly assigned to receive 120 mg per day of Ginkgo biloba extract (ginkgo; standardized to contain 24% flavone glycosides and 6% terpene lactones) or placebo in addition to clozapine for 12 weeks. The mean percent improvement in negative symptoms (as assessed by the Scale for the Assessment of Negative Symptoms [SANS]) was significantly greater in the ginkgo group than in the placebo group (15.6% vs. 3.5%; p < 0.04). Compared with placebo, ginkgo had no significant effect on positive symptoms or overall psychopathology symptoms.

[ILLUSTRATION OMITTED]

Comment: Schizophrenia is a chronic, debilitating disease that frequently fails to respond adequately to antipsychotic medication. Schizophrenia is characterized by a wide array of mental symptoms, which are classified as either "positive" or "negative." The positive symptoms, which include delusions, paranoid thoughts, and hallucinations, frequently respond to treatment with antipsychotic drugs. The negative symptoms, on the other hand, which include blunting of the emotions, social withdrawal, and impairment of cognitive function, often fail to respond to treatment. The results of the present study suggest that ginkgo can enhance the effect of clozapine on negative symptoms in patients with treatment-resistant schizophrenia.

Doruk A et al. A placebo-controlled study of extract of ginkgo bilona added to clozapine in patients with treatment-resistant schizophrenia. Int Clin Psychopharmacol. 2008;23:223-227.

by Alan R. Gaby, MD drgaby@earthlink.net
COPYRIGHT 2009 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Literature Review & Commentary
Author:Gaby, Alan R.
Publication:Townsend Letter
Article Type:Brief article
Geographic Code:1USA
Date:May 1, 2009
Words:237
Previous Article:Cranberry extract lowers cholesterol levels.
Next Article:Good nutrition enhances recovery from strokes.
Topics:


Related Articles
Scientific review of Ginkgo Biloba published. (Top of the News).
Ginkgo biloba in dyslexia: a pilot study.
Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation.
Ginkgo biloba and treatment resistant schizophrenia.
Ginkgo study shows disappointing results.
Daily dose of Ginkgo biloba may prevent brain damage from stroke.
Adulteration suspected with some 'memory' supplements.
Cognitive effects of a ginkgo biloba/vinpocetine compound in normal adults: systematic assessment of perception, attention and memory.
Bioactivity of Ginkgo extracts: the role of terpene lactones.
Women's health update.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters